Abstract

The lysosome, a key organelle for cellular clearance, is associated with a wide variety of pathological conditions in humans. Lysosome function and its related pathways are particularly important for maintaining the health of the cardiovascular system. In this review, we highlighted studies that have improved our understanding of the connection between lysosome function and cardiovascular diseases with an emphasis on a recent breakthrough that characterized a unique autophagosome-lysosome fusion mechanism employed by cardiomyocytes through a lysosomal membrane protein LAMP-2B. This finding may impact the development of future therapeutic applications.

Highlights

  • The lysosome is a membrane-bound cell organelle that contains digestive enzymes

  • There are many causative factors that contribute to the pathogenesis of cardiovascular diseases, lysosome function is tightly correlated with the progression of these diseases [4]

  • Using an autophagic flux assay, we found that only LAMP-2B KO hiPSC-CMs displayed an autophagy defect, which was not observed in LAMP-2A or LAMP-2C KO hiPSC-CMs

Read more

Summary

Introduction

The lysosome is a membrane-bound cell organelle that contains digestive enzymes. Lysosome-mediated degradation is considered to be one of the major mechanisms by which cells degrade long-lived or damaged proteins and organelles [1]. Consistent with its key functions in maintaining cellular hemostasis, defects in lysosome functions lead to the development of many human diseases, including cardiovascular diseases [2]. Cardiovascular disease is the leading global cause of death. There are many causative factors that contribute to the pathogenesis of cardiovascular diseases, lysosome function is tightly correlated with the progression of these diseases [4]. We highlighted new mechanisms by which lysosomes contribute to the pathogenesis of cardiovascular diseases and discuss potential therapeutic strategies for clinical applications

Lysosome Dysfunction and Cardiovascular Diseases
Phenotypes of Danon Cardiomyopathy
Defective Autophagy Correlates to Danon Cardiomyopathy
A Novel Mechanism of LAMP-2B in Autophagosome-Lysosome Fusion in CMs
Gene Therapy to Treat LSDs
Perspectives
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call